FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Decision Denying Vanda sNDA Hearing

[ Price : $8.95]

Federal Register notice: FDA makes available its decision to deny a request for a hearing on a CDER-proposed decision to not appro...

Info Collection Revision on NDA Form

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection revision entitled Applications for FDA Approval To Market a Ne...

Medfusion Syringe Pump Recalled Over Software

[ Price : $8.95]

Smiths Medical ASD recalls its Medfusion model 3500 syringe pump due to software-related issues that can cause the device to fail ...

sNDA for Ozempic Planned for Kidney Disease

[ Price : $8.95]

Novo Nordisk says it will file a supplemental NDA this year seeking an expanded label for Ozempic (semaglutide) for preventing pro...

FDA Approves Sandoz Prolia, Xgeva Biosimilars

[ Price : $8.95]

FDA approves Sandoz Jubbonti and Wyost, the first interchangeable biosimilars for Amgens Prolia and Xgeva.

Budget Compromise Gives FDA $160 Million Boost

[ Price : $8.95]

Senate and House appropriators post a joint spending bill agreement for fiscal year 2024 that would provide FDA with a $160 millio...

1st OTC Continuous Glucose Monitor Cleared

[ Price : $8.95]

FDA clears a Dexcom 510(k) for the companys Stelo Glucose Biosensor System, which the agency says is the first over-the-counter co...

Info Collection on FDA Drug Communications

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection extension entitled Data to Support Drug Product Communications...

Bell Intrnatl. Labs Warned Over CGMP Violations

[ Price : $8.95]

FDA warns Eagan, MN-based Bell International Laboratories about CGMP violations in its production of finished drugs.

CGMP Violations Found at Colgin

[ Price : $8.95]

FDA warns Dallas, TX-based Colgin, Inc., about CGMP violations in its production of finished drugs.